Clear Point Advisors’s GE HealthCare GEHC Stock Holding History

Clear Point Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21	Closed	-$1.97K	–	277
2024 Q3	$1.97K	Hold	21	–	–	﹤0.01%	446
2024 Q2	$1.64K	Hold	21	–	–	﹤0.01%	449
2024 Q1	$1.91K	Hold	21	–	–	﹤0.01%	439
2023 Q4	$1.62K	Buy	+21	New	+$1.47K	﹤0.01%	432

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Clear Point Advisors's GEHC Position: Q4 2024 in Review

Clear Point Advisors sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 21 shares — an estimated $1.97K sold.

Clear Point Advisors first reported a position in GEHC in Q4 2023 and held it in 4 quarters. The position peaked at $1.97K in Q3 2024. 1,327 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

Clear Point Advisors reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
Clear Point Advisors sold 21 GE HealthCare shares in Q4 2024, an estimated $1.97K.
Clear Point Advisors first reported a position in GE HealthCare in Q4 2023 and held it in 4 quarters.
Clear Point Advisors's GE HealthCare position peaked at $1.97K in Q3 2024.
1,327 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on Clear Point Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.